Abstract

Respiratory tract infections are a major cause of morbidity and mortality worldwide in young children. Concepts such as the gut-lung axis have highlighted the impact of microbial communities at distal sites in mediating disease locally. However, little is known about the extent to which microbial communities from multiple body sites are linked, and how this relates to disease susceptibility. Here, we combine 16S-based rRNA sequencing data from 112 healthy, term born infants, spanning three body sites (oral cavity, nasopharynx, gut) and the first six months of life. Using a cross-niche microbial network approach, we show that, already from the first week of life on, there is a strong association between both network structure and species essential to these structures (hub species), and consecutive susceptibility to respiratory tract infections in this cohort. Our findings underline the crucial role of cross-niche microbial connections in respiratory health.

In order to assess the extent by which microbial communities from multiple body sites are linked and related to disease susceptibility, Reyman and Clerc et al. combined 16S-based rRNA sequencing data from 112 healthy, term born infants, spanning three body sites (oral cavity, nasopharynx, gut) over the first six months of life. They demonstrate a strong association between network structure and species and susceptibility to respiratory tract infections, suggesting a crucial role of cross-niche microbial connections in respiratory health.

Details

Title
Microbial community networks across body sites are associated with susceptibility to respiratory infections in infants
Author
Reyman Marta 1 ; Clerc, Melanie 2 ; van Houten Marlies A 3 ; Arp Kayleigh 4 ; Chu Mei Ling J N 4 ; Raiza, Hasrat 4 ; Sanders Elisabeth A M 4   VIAFID ORCID Logo  ; Bogaert Debby 5   VIAFID ORCID Logo 

 Wilhelmina Children’s Hospital, University Medical Centre Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands (GRID:grid.416219.9) (ISNI:0000 0004 0568 6419); Erasmus Medical Center, Department of Dermatology, Rotterdam, The Netherlands (GRID:grid.5645.2) (ISNI:000000040459992X) 
 University of Edinburgh, Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988); Institute of Microbiology, ETH Zürich, Zürich, Switzerland (GRID:grid.5801.c) (ISNI:0000 0001 2156 2780) 
 Spaarne Gasthuis Academy, Hoofddorp and Haarlem, The Netherlands (GRID:grid.416219.9) (ISNI:0000 0004 0568 6419) 
 Wilhelmina Children’s Hospital, University Medical Centre Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); National Institute for Public Health and the Environment, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118) 
 Wilhelmina Children’s Hospital, University Medical Centre Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); University of Edinburgh, Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2587504232
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.